The discovery and development of perampanel for the treatment of epilepsy

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.9, Iss.4, 2014-04, pp. : 449-458

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

AMPA receptor inhibitors for the treatment of epilepsy: the role of perampanel

By Zaccara Gaetano Giovannelli Fabio Cincotta Massimo Iudice Alfonso

Expert Review of Neurotherapeutics, Vol. 13, Iss. 6, 2013-06 ,pp. : 647-655

Informa Healthcare

Access to resources Recommend Favorite

The preclinical discovery and development of ezogabine for the treatment of epilepsy

By Jankovic Slobodan Ilickovic Ivana

Expert Opinion on Drug Discovery, Vol. 8, Iss. 11, 2013-11 ,pp. : 1429-1437

Informa Healthcare

Access to resources Recommend Favorite

Discovery of epilepsy susceptibility genes: implications for therapy development and pharmacogenomics

By Ferraro Thomas N

Pharmacogenomics, Vol. 13, Iss. 7, 2012-05 ,pp. : 731-734

Future Medicine

Access to resources Recommend Favorite

The discovery and development of vandetanib for the treatment of thyroid cancer

By Sim Michael W Cohen Mark Steven

Expert Opinion on Drug Discovery, Vol. 9, Iss. 1, 2014-01 ,pp. : 105-114

Informa Healthcare

Access to resources Recommend Favorite

Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment

By Patel Hardik J Modi Shanu Chiosis Gabriela Taldone Tony

Expert Opinion on Drug Discovery, Vol. 6, Iss. 5, 2011-05 ,pp. : 559-587

Informa Healthcare

Access to resources Recommend Favorite